Cash for clinic visits: new study tests financial incentives to keep opioid patients in treatment

NCT ID NCT07129902

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study tests whether offering financial incentives (contingency management) can help people who started medication for opioid use disorder in the emergency department keep attending outpatient treatment. Thirty adults will be randomly assigned to receive either standard care or standard care plus payments for showing up to clinic appointments. The goal is to see if the incentives improve treatment attendance and reduce opioid use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
monetary incentive (contingency management)
What this could lead to
If it works, this approach could improve treatment attendance and reduce relapse for people starting medication for opioid use disorder in the emergency department.
What could go wrong
This is a very small pilot study (30 people) testing a behavioral intervention, not a new drug. Results may not apply to other settings or larger populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Vermont Medical Center

    RECRUITING

    Burlington, Vermont, 05405, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.